Literature DB >> 29306698

Gender differences in C-reactive protein and homocysteine modulation of cognitive performance and real-world functioning in bipolar disorder.

M Sanchez-Autet1, B Arranz2, G Safont3, P Sierra4, A Garcia-Blanco5, L de la Fuente6, M Garriga7, M P García-Portilla6.   

Abstract

BACKGROUND: Cognitive and psychosocial impairment has been associated with increased levels of C-reactive protein (CRP) and homocysteine in bipolar disorder, but gender differences have seldom been studied.
METHODS: Two hundred and twenty-four bipolar outpatients were included. Cognitive performance was assessed through the Screen for Cognitive Impairment in Psychiatry (SCIP). Psychosocial functioning was evaluated using the Functioning Assessment Short Test (FAST) and the General Assessment of Functioning (GAF). Homocysteine and CRP levels were determined. Separate analyses were performed by gender. Partial correlations were calculated to test for associations between biomarkers and cognitive and psychosocial functioning. Hierarchical multiple regression was used to assess factors predicting cognitive and psychosocial functioning. Covariates were: age, education, duration of illness, hospital admissions, depressive symptoms, tobacco consumption, and BMI.
RESULTS: A better performance was noted in women in delayed verbal learning (p = 0.010), along with better occupational functioning (p = 0.027) and greater leisure time impairment (p = 0.034). In men, CRP and homocysteine levels were associated with psychosocial dysfunction (interpersonal relationships and financial functioning, respectively). In women, CRP levels correlated with cognitive performance (SCIP total raw score, immediate and delayed verbal learning, and verbal fluency). CRP was a predictor of cognitive performance in women only. LIMITATIONS: The choice of the cognitive scale and covariates and the lack of a control group may be the main limitations.
CONCLUSIONS: A gender difference was found in biomarker modulation of cognition and psychosocial functioning. A gender-based approach to cognition and real-world functioning should be considered in bipolar disorder to ensure an optimal outcome.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29306698     DOI: 10.1016/j.jad.2017.12.038

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis.

Authors:  M Morrens; C Overloop; V Coppens; E Loots; M Van Den Noortgate; S Vandenameele; M Leboyer; L De Picker
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

2.  The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo-controlled, clinical trial.

Authors:  Rahim Badrfam; Seyed-Ali Mostafavi; Ali Khaleghi; Shahin Akhondzadeh; Atefeh Zandifar; Malihe Farid; Nami Mohammadian Khonsari; Mohammad Reza Mohammadi
Journal:  Brain Behav       Date:  2021-10-17       Impact factor: 2.708

3.  Relationship Among Homocysteine, Inflammation and Cognitive Impairment in Patients with Acute Ischemic Stroke and Transient Ischemic Attack.

Authors:  Lingyun Cui; Ping Lu; Shiyu Li; YueSong Pan; Mengxing Wang; Zixiao Li; Xiaoling Liao; Yongjun Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-11       Impact factor: 2.570

4.  High-sensitivity C-reactive protein is related to age and gender in an acute psychiatric inpatient population.

Authors:  Yuki Sakai; Jeanette Brun Larsen; Solveig Klæbo Reitan
Journal:  Heliyon       Date:  2022-02-19

Review 5.  The relations between executive functions and occupational functioning in individuals with bipolar disorder: a scoping review.

Authors:  Juul Koene; Susan Zyto; Jaap van der Stel; Natasja van Lang; Marion Ammeraal; Ralph W Kupka; Jaap van Weeghel
Journal:  Int J Bipolar Disord       Date:  2022-03-14

6.  Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences.

Authors:  Francesco Dal Santo; Leticia González-Blanco; Leticia García-Álvarez; Lorena de la Fuente-Tomás; Ángela Velasco; Clara María Álvarez-Vázquez; Clara Martínez-Cao; Pilar A Sáiz; María Paz García-Portilla; Julio Bobes
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.